COST AND HEALTHCARE RESOURCE UTILIZATION (HRU) RESULTING FROM IMMUNE-RELATED ADVERSE EVENTS (IRAES) AMONG PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS (ICIS)

被引：0
|
作者：
Zheng, Y. [1 ]
Kim, R. [2 ]
Yu, T. [1 ]
Dreyfus, J. [3 ]
Gayle, J. A. [3 ]
Wassel, C. L. [3 ]
Phatak, H. [1 ]
George, S. [4 ]
机构：
[1] EMD Serono Inc, Rockland, MA USA
[2] Pfizer Inc, New York, NY USA
[3] Premier Inc, Charlotte, NC USA
[4] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN171
引用
收藏
页码：S469 / S469
页数：1
相关论文
共 50 条
  • [21] Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors
    Ornstein, Moshe C.
    Calabrese, Cassandra
    Wood, Laura S.
    Kirchner, Elizabeth
    Profusek, Pamela
    Allman, Kimberly D.
    Martin, Allison
    Kontzias, Arstolos
    Grivas, Petros
    Garcia, Jorge A.
    Calabrese, Leonard H.
    Rini, Brian, I
    CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : 177 - 182
  • [22] Assessing immune-related adverse events among Chinese cancer patients receiving ICIs
    Reactions Weekly, 2025, 2041 (1) : 3 - 3
  • [23] Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors
    Yang, Kaili
    Li, Jiarui
    Sun, Zhao
    Bai, Chunmei
    Zhao, Lin
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3907 - 3918
  • [24] Corticosteroids for the management of immune-related adverse events in patients receiving checkpoint inhibitors
    Williams, Kiersten J.
    Grauer, Dennis W.
    Henry, David W.
    Rockey, Michelle L.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (03) : 544 - 550
  • [25] Immune-related Adverse Events in Patients With Cancer Receiving Influenza Vaccination and Immune Checkpoint Inhibitors
    Groeneveld, Geert H.
    Wijn, Dirk H.
    Vollaard, Albert M.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1519 - 1519
  • [26] CARDIAC IMMUNE-RELATED ADVERSE EVENTS IN LUNG CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Kumar, Sany
    Fowler, Cosmo
    Thota, Ajit K.
    Pastores, Stephen M.
    CHEST, 2023, 164 (04) : 363A - 363A
  • [27] Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors
    Kaili Yang
    Jiarui Li
    Zhao Sun
    Chunmei Bai
    Lin Zhao
    Clinical and Experimental Medicine, 2023, 23 : 3907 - 3918
  • [28] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Abdel-Wahab, Noha
    Diab, Adi
    Yu, Robert K.
    Futreal, Andrew
    Criswell, Lindsey A.
    Tayar, Jean H.
    Dadu, Ramona
    Shannon, Vickie
    Shete, Sanjay S.
    Suarez-Almazor, Maria E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1939 - 1949
  • [29] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Noha Abdel-Wahab
    Adi Diab
    Robert K. Yu
    Andrew Futreal
    Lindsey A. Criswell
    Jean H. Tayar
    Ramona Dadu
    Vickie Shannon
    Sanjay S. Shete
    Maria E. Suarez-Almazor
    Cancer Immunology, Immunotherapy, 2021, 70 : 1939 - 1949
  • [30] Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy
    Zhou, Nanruoyi
    Velez, Maria A.
    Owen, Dwight
    Lisberg, Aaron E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (09): : 1287 - 1290
12345